Login / Signup

Relationship Between Interleukin-6 -174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients.

Renata SokolikMilena IwaszkoJerzy ŚwierkotBarbara WysoczańskaLucyna KormanPiotr WilandKatarzyna Bogunia-Kubik
Published in: Pharmacogenomics and personalized medicine (2021)
Results from this study provide evidence that the IL-6 -174 G/C polymorphism might influence efficacy of MTX treatment.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • high dose
  • gene expression
  • prognostic factors
  • low dose
  • replacement therapy